This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

China's cybersecurity standards body issues draft guidance on OpenClaw AI agent

( April 1, 2026, 04:28 GMT | Official Statement) -- MLex Summary: China’s TC260, the nation’s cybersecurity standards body, on Tuesday issued a draft practice guide outlining security requirements for deploying and using open-source OpenClaw class AI agents, to mitigate cybersecurity risks and strengthen governance of the systems. The draft sets out measures across installation, configuration, use and removal stages, as well as cloud security, supply-chain controls and organizational oversight, including the management of employees’ “shadow agents” deployed without approval. It targets individual users and organizations deploying open-source AI agents but excludes commercialized systems. The draft guidelines will be open for public comments until April 15.Statement follows. The draft of Cybersecurity Standards Practice Guidelines is attached (both in Chinese). ...

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login

Documents

Related Sections